CFML
BSX icon

COMPASS FINANCIAL MANAGEMENT LLC’s Boston Scientific BSX Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.07K Buy
+193
New +$10.5K ﹤0.01% 1082

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's BSX Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Boston Scientific (BSX) in Q2 2026: 193 shares worth $9.07K. The stake represents ﹤0.01% of the portfolio and ranks #1082 among its holdings.

1,102 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 193 shares of Boston Scientific worth $9.07K as of Q2 2026.
  • Boston Scientific was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1082 holding.
  • 1,102 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.